The population of patients with hepatocellular carcinoma (HCC) overlaps to a high degree
with those for chronic kidney disease (CKD) and end-stage renal disease (ESRD). The …

The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
represents the first update to this set of recommendations since the initial set of KDIGO …

Introduction: Hepatitis B virus is an important cause of liver disease and has numerous extra-
hepatic manifestations. HBV leads to important morbidity and mortality in the general …

Background and aims We aimed to compare the longitudinal changes in estimated
glomerular filtration rate (eGFR) in chronic hepatitis B (CHB) patients treated with entecavir …

Background Currently, several studies have observed that chronic hepatitis B virus infection
is associated with the pathogenesis of kidney disease. However, the extent of the correlation …

Kidney-liver crosstalk plays a crucial role in normal and certain pathological conditions. In
pathologic states, both renal-induced liver damage and liver-induced kidney diseases may …

Background Although studies have found an association between chronic kidney disease
(CKD) and cancer incidence, the results are inconsistent. Methods This study included …

Chronic viral hepatitis is one of the leading causes of cirrhosis worldwide. Chronic hepatitis
B is more common in the Asia-Pacific region due to the larger population and lower …

Background The activity of hepatitis B virus (HBV) as a risk factor for the incidence and
progression of chronic kidney disease (CKD) has not been clarified. Aim We evaluated the …

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as
follows: Primary objectives We aim to evaluate the beneficial and harmful effects of: hepatitis …